ALKEM LAB LTD (ALKEM.NS) Financials
ALKEM.NS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 149.3 billion | 47.0 billion |
| 2023-06-30 | ? | ? |
| 2023-03-31 | 137.6 billion | 43.2 billion |
ALKEM.NS Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 1.4 billion | ? |
| 2023-09-30 | 1.5 billion | ? |
| 2023-06-30 | 1.4 billion | ? |
| 2023-03-31 | 1.6 billion | ? |
ALKEM.NS Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 5.9 billion |
| 2023-09-30 | 6.2 billion |
| 2023-06-30 | 2.9 billion |
| 2023-03-31 | 709.8 million |
ALKEM.NS Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 36.1 billion | - | - |
| 2023-09-30 | 38.3 billion | 3.6 billion | 2.0 billion |
| 2023-06-30 | 11.4 billion | - | - |
| 2023-03-31 | 31.2 billion | 703.3 million | 895.3 million |
ALKEM.NS Shares Outstanding
ALKEM.NS Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | 1.1 billion | - | - |
| 2023-09-30 | 1.2 billion | 1.2 billion | 5.6 billion | - |
| 2023-06-30 | - | 1.2 billion | 5.7 billion | - |
| 2023-03-31 | 2.3 billion | 1.5 billion | -1.7 billion | 8.2 billion |
ALKEM.NS Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 33.2 billion | 13.0 billion |
| 2023-09-30 | 34.4 billion | 13.3 billion |
| 2023-06-30 | 29.7 billion | 12.0 billion |
| 2023-03-31 | 29.0 billion | 12.6 billion |
ALKEM.NS
Price: ₹5,456.25
Dividend Yield: 0.85%
Forward Dividend Yield: 1.28%
Payout Ratio: 53.18%
Dividend Per Share: 70.00 INR
Earnings Per Share: 133.35 INR
P/E Ratio: 40.16
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 635.4 billion
Average Dividend Frequency: 2
Years Paying Dividends: 9
DGR3: 0.40%
DGR5: 20.24%